Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01438112
Title Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer (BOND)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors CG Oncology, Inc.
Indications

bladder urothelial carcinoma

Therapies

Valrubicin

Mitomycin C

CG0070

Interferon gamma

Gemcitabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.